Skip to main content

Impact Biomedical Inc.

IBO
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001834105

In the last 90 days, Impact Biomedical Inc. insiders filed 0 open-market purchases and 1 sale; 23 institutions reported holding it in 13F filings for Q2 2026, worth $1.76M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Impact Biomedical Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
1 filing
1 insider, $1.69K in total
Insiders trading
1
Net value
−$1.69K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Impact Biomedical Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Impact Biomedical Inc.
NameTitleLast reported holdingLast filingFilings, past year
DSS, Inc.10% Owner589,518Sep 24, 20262
Macko Todd DChief Financial Officer155,122Mar 30, 20261
Grady JasonDirector250,182Mar 25, 20261
Chan Heng Fai AmbroseDirector0IndirectApr 7, 20250
Alset International Ltd10% Owner0IndirectApr 4, 20250
Alset Inc.10% Owner0IndirectApr 4, 20250
Heuszel Frank DChief Executive Officer97,344Dec 9, 20240

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 24, 2026 (view filing)7:37 PM ETSep 22-242 daysDSS, Inc.10% OwnerSSale−906$1.86−$1.69K−0.2%589.5K after3 lots
Mar 30, 2026 (view filing)Mar 25-275 daysLateMacko Todd DChief Financial OfficerSSale−45.0K$0.5614−$25.3K−22.5%155.1K after2 lots
Mar 25, 2026 (view filing)Mar 232 daysGrady JasonDirectorSSale−50.0K$0.65−$32.5K−16.7%250.2K after
Jan 6, 2026 (view filing)May 22-27, 2025229 daysLateDSS, Inc.10% OwnerSSale−161.0K$0.5472−$88.1K−22.8%545.0K after2 lots
May 27, 2025 (view filing)May 22-275 daysDSS, Inc.10% OwnerSSale−161.0K$0.5472−$88.1K−100.0%0 after2 lots
Apr 7, 2025 (view filing)Apr 43 daysDSS, Inc.10% OwnerSSale−890.8K$0.95−$846.3K−84.7%161.1K after
Apr 7, 2025 (view filing)Apr 34 daysChan Heng Fai AmbroseDirectorSSale−351.6K$0.50−$175.8K−100.0%0 after
Apr 4, 2025 (view filing)5:15 PM ETApr 2-42 daysChan Heng Fai Ambrose and 2 othersDirector, 10% OwnerSSale−1.69M$0.6646−$1.12M−100.0%0 after7 lots
Apr 2, 2025 (view filing)9:01 PM ETMar 31-Apr 12 daysChan Heng Fai Ambrose and 2 othersDirector, 10% OwnerSSale−2.13M$1.18−$2.52M−74.3%734.1K after3 lots
Apr 2, 2025 (view filing)9:01 PM ETApr 11 dayChan Heng Fai Ambrose and 2 othersDirector, 10% OwnerSSale−400.0K$0.982−$392.8K−31.9%853.9K after
Mar 28, 2025 (view filing)Mar 217 daysLateDSS, Inc.10% OwnerSSale−499.8K$3.30−$1.65M−29.8%1.18M after3 lots
Mar 28, 2025 (view filing)Mar 26-272 daysDSS, Inc.10% OwnerSSale−105.8K$2.85−$301.4K−9.1%1.05M after3 lots
Mar 24, 2025 (view filing)Dec 2, 2024-Mar 20, 2025112 daysLateDSS, Inc.10% OwnerSSale−53.3K$4.68−$249.4K−100.0%0 after2 lots
Mar 24, 2025 (view filing)Mar 204 daysDSS, Inc.10% OwnerPPurchase+200$1.55+$310+0.4%53.3K after
Dec 9, 2024 (view filing)Dec 54 daysHeuszel Frank DChief Executive OfficerPPurchase+500$2.26+$1.13K+0.5%97.3K after
Dec 3, 2024 (view filing)Nov 276 daysLateHeuszel Frank DChief Executive OfficerPPurchase+500$2.61+$1.30K+0.5%96.8K after
Dec 3, 2024 (view filing)Nov 267 daysLateHeuszel Frank DChief Executive OfficerPPurchase+1.05K$2.61+$2.74K+1.1%96.3K after2 lots
Nov 22, 2024 (view filing)Nov 12-1810 daysLateDSS, Inc.10% OwnerSSale−5.70K$2.99−$17.0K−9.7%53.1K after3 lots
Sep 19, 2024 (view filing)Sep 181 dayDSS, Inc.10% OwnerPPurchase+1.00K$2.33+$2.33K+1.7%58.8K after
Sep 18, 2024 (view filing)Sep 16-172 daysDSS, Inc.10% OwnerPPurchase+57.8K$2.65+$153.2KNew position57.8K after2 lots